Keyue Liu

Medical Development Field
Okayama, 7008558, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Anti-HMGB1 Antibody Therapy Ameliorates Spinal Cord Ischemia-Reperfusion Injury in Rabbits.

Anti-HMGB1 Antibody Therapy Ameliorates Spinal Cord Ischemia-Reperfusion Injury in Rabbits.

Journal: International journal of molecular sciences

Published: July 29, 2025

Glucocorticoids induce HMGB1 release in primary cultured rat cortical microglia.

Glucocorticoids induce HMGB1 release in primary cultured rat cortical microglia.

Journal: Neuroscience

Published: June 30, 2024

Anti-HMGB1 mAb Therapy Reduces Epidural Hematoma Injury.

Anti-HMGB1 mAb Therapy Reduces Epidural Hematoma Injury.

Journal: International journal of molecular sciences

Published: April 22, 2024

Perineural Treatment with High Mobility Group Box-1 Monoclonal Antibody Prevents Initiation of Pain-Like Behaviors in Female Mice with Trigeminal Neuropathy.

Perineural Treatment with High Mobility Group Box-1 Monoclonal Antibody Prevents Initiation of Pain-Like Behaviors in Female Mice with Trigeminal Neuropathy.

Journal: Biological & pharmaceutical bulletin

Published: January 21, 2024

Repeated Social Defeat Stress Induces HMGB1 Nuclear Export in Prefrontal Neurons, Leading to Social Avoidance in Mice.

Repeated Social Defeat Stress Induces HMGB1 Nuclear Export in Prefrontal Neurons, Leading to Social Avoidance in Mice.

Journal: Cells

Published: June 23, 2023

Protective effects of an anti-4-HNE monoclonal antibody against liver injury and lethality of endotoxemia in mice.

Protective effects of an anti-4-HNE monoclonal antibody against liver injury and lethality of endotoxemia in mice.

Journal: European journal of pharmacology

Published: January 18, 2023

Treatment of Marmoset Intracerebral Hemorrhage with Humanized Anti-HMGB1 mAb.

Treatment of Marmoset Intracerebral Hemorrhage with Humanized Anti-HMGB1 mAb.

Journal: Cells

Published: August 23, 2022

HMGB1 in the mPFC governs comorbid anxiety in neuropathic pain.

HMGB1 in the mPFC governs comorbid anxiety in neuropathic pain.

Journal: The journal of headache and pain

Published: July 07, 2022

Histamine induced high mobility group box-1 release from vascular endothelial cells through H1 receptor.

Histamine induced high mobility group box-1 release from vascular endothelial cells through H1 receptor.

Journal: Frontiers in immunology

Published: April 28, 2022

High-mobility group box 1-mediated hippocampal microglial activation induces cognitive impairment in mice with neuropathic pain.

High-mobility group box 1-mediated hippocampal microglial activation induces cognitive impairment in mice with neuropathic pain.

Journal: Experimental neurology

Published: March 25, 2022

Central high mobility group box-1 induces mechanical hypersensitivity with spinal microglial activation in a mouse model of hemi-Parkinson's disease.

Central high mobility group box-1 induces mechanical hypersensitivity with spinal microglial activation in a mouse model of hemi-Parkinson's disease.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 07, 2021

Decreased levels of histidine-rich glycoprotein and increased levels of high-mobility group box 1 are risk factors for refractory Kawasaki disease.

Decreased levels of histidine-rich glycoprotein and increased levels of high-mobility group box 1 are risk factors for refractory Kawasaki disease.

Journal: Modern rheumatology

Published: August 03, 2021

Showing 1-12 of 61

Last Updated: 09/26/2026